TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
GWRE

Guidewire Software Inc

Technology · Software - Application

151.00$ -1.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow GWRE
Line item 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
– – -16.2% +190.4% -38.3% +90.4% +131.9% -15.6% +56.9% +37.3% +2.4% -17.3% -2.6% -1.3% -134.0% – +409.8% +53.7% +30.9%
– +10.2% +5.4% +61.8% +31.0% +65.3% +40.0% +10.8% +18.2% +111.8% +90.2% +12.2% +6.7% -13.3% -9.2% -25.9% -10.2% +6.5% -8.7%
– – +20.3% +99.2% +173.3% +110.3% +10.8% +20.8% +28.7% +8.6% +24.8% +2.1% +11.3% +13.0% +19.1% +4.3% +2.5% +10.3% +12.5%
– – – – – +40.3% +11.9% +45.8% +1.4% +14.6% +70.3% -32.6% +44.1% -14.6% +3.0% +33.8% – – –
– +173.4% -154.3% – -313.1% – – -137.7% – +95.8% -58.8% -313.5% – – -132.2% – – -78.5% -82.9%
– -30.1% +91.4% +24.0% +102.4% +64.2% -45.9% +26.2% +12.9% -6.2% +80.1% +306.8% -47.5% +12.4% -24.5% -20.0% +6.3% -69.0% +110.0%
– -46.6% +2.0% +699.0% -60.3% +4,418.0% +155.5% – -538.9% +11.9% +374.3% -43.9% -98.1% – +386.4% -95.9% -511.9% +352.6% -42.6%
– – – – – – – – – – – – – – – – – – –
– – – – – -93.7% +4,265.8% -98.4% -123.6% – +3,907.9% -98.2% +25.3% -3,355.7% -76.8% +599.1% -100.0% – –
– – – – – – – – +0.0% +0.0% +0.0% – – – – – – – -100.0%
– -99.6% +1,089.4% +18.6% +14,186.5% -106.5% – -104.7% – +8.7% +3,816.6% -99.3% +25.3% -3,316.7% -76.6% +600.6% – +7,700.3% -808.7%
– – -0.6% +126.1% +557.7% -186.2% – -6.0% -82.5% +252.9% +339.4% -205.2% – -84.1% +1,180.7% -190.5% – +5.3% -317.6%
– – -28.5% +241.4% -53.9% +103.2% +202.3% -18.6% +61.7% +40.6% -1.6% -47.6% +29.9% -5.3% -172.2% – +745.2% +66.5% +28.0%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?